HomeNewsGlobal Pharma

Investment firm Bridgewest Group buys Pfizer manufacturing facility in Australia

Investment firm Bridgewest Group buys Pfizer manufacturing facility in Australia

Bridgewest Group has bought up another Pfizer manufacturing facility in Australia. The San Diego-based investment firm has agreed to purchase a sterile injectables site near Perth.

The facility has extensive blow, fill and seal capabilities and supplies products including speciality oncology drugs to more than 90 countries. As part of the deal, Bridgewest also will gain an undisclosed group of drugs from Pfizer. The company plans to aggressively market the products in a bid to grow market share, it said.

Additionally, it will supply other products to Pfizer under a manufacturing and supply agreement, Bridgewest said.

Read more on:
Bridgewest Group Pfizer
More news about: global pharma | Published by Sudeep Soparkar | November - 15 - 2022 | 454

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members